New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Thermo Fisher Scientific Inc.
TMO
Shape
US Flag

NYSE

203B

Medical - Diagnostics & Research

Next Earning date - 29 Jan 2025

203B

Medical - Diagnostics & Research

Next Earning date - 29 Jan 2025

529.63USD
Shape7.97 ( 1.53%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

40%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated December 1, 2024
1W 3.00 % 1M -4.65 % 3M -12.61 % 1Y 7.21 %

Key Metrics

Shape
  • Market Cap

    202.58B


  • Shares Outstanding

    382.50M


  • Share in Float

    381.97M


  • Dividende

    1.56


  • Earning Date

    29 Jan 2025


  • Price Target

    529.63


  • Average Volume

    1.51M


  • Beta

    0.792


  • Range

    487.06-627.88


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.thermofisher.com


  • Sector

    Healthcare


Fundamentals

Shape

24.71x

P/E Ratio

4.78x

P/S Ratio

4.13x

P/B Ratio

0.7

Debt/Equity

14.5%

Net Margin

$16.0

EPS

How TMO compares to sector?

P/E Ratio

Relative Strength

Shape

TMO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$45B

Shape326%

2025-Revenue

$23.55

Shape451%

2025-EPS

$13B

Shape343%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Stephens

initialise

Previous: Not converted

2024-09-30

Now: Overweight

Wells Fargo

initialise

Previous: Underweight

2024-08-27

Now: Overweight

Jefferies

upgrade

Previous: Not converted

2024-06-03

Now: Buy

CFRA

upgrade

Previous: Not converted

2024-03-25

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-17%

5.4
vs 6.54

Q2.23

arrow
arrow

-31%

5.03
vs 7.25

Q3.23

arrow
arrow

-7%

5.15
vs 5.51

Q3.23

arrow
arrow

+3%

5.69
vs 5.51

Q4.23

arrow
arrow

+5%

5.67
vs 5.4

Q1.24

arrow
arrow

N/A

5.11
vs NA

Q2.24

arrow
arrow

+7%

5.37
vs 5.03

Q3.24

arrow
arrow

-7%

5.28
vs 5.69

Q4.24

arrow
arrow

+5%

5.94
vs 5.67

Q1.25

arrow
arrow

+6%

5.44
vs 5.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+7%

11.4B  vs 10.7B

Q2.23

arrow
arrow

-9%

10.7B  vs 11.8B

Q3.23

arrow
arrow

-3%

10.7B  vs 11B

Q3.23

arrow
arrow

-4%

10.6B  vs 11B

Q4.23

arrow
arrow

-5%

10.9B  vs 11.4B

Q1.24

arrow
arrow

NA

10.3B  vs NA

Q2.24

arrow
arrow

-2%

10.5B  vs 10.7B

Q3.24

arrow
arrow

+0%

10.6B  vs 10.6B

Q4.24

arrow
arrow

+4%

11.3B  vs 10.9B

Q1.25

arrow
arrow

+4%

10.8B  vs 10.3B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+4%

0.04
vs 0.03

Q2.23

arrow
arrow

+3%

0.03
vs 0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.03

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Q3.24

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

2428

2.4K
vs 2.3K

5%

Q1.23

arrow
arrow

2421

2.4K
vs 2.4K

0%

Q2.23

arrow
arrow

2433

2.4K
vs 2.4K

1%

Q3.23

arrow
arrow

2409

2.4K
vs 2.4K

-1%

Q4.23

arrow
arrow

2539

2.5K
vs 2.4K

5%

Q1.24

arrow
arrow

2563

2.6K
vs 2.5K

1%

Q2.24

arrow
arrow

2576

2.6K
vs 2.6K

1%

Q3.24

arrow
arrow

2579

2.6K
vs 2.6K

0%

Earnings Growth

Latest News